Fundz

NorthStar and QSA Global Form Strategic Partnership to Enhance Actinium-225 Supply Chain for Targeted Alpha Therapies

May 27, 2026

Contract Type

partnership

BeloitBiotechnologyHealth CareMedicalMedical Device

Description

NorthStar Medical Radioisotopes and QSA Global have entered into a multi-year strategic partnership to solidify the supply chain for Radium-226, essential for Actinium-225 production. This agreement aims to enhance the quality and reliability of the radioactive material supply used in next-generation therapies.

Company Information

Company

NorthStar Medical Technologies

Location

Beloit, Wisconsin, United States

About

NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, is a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases.

Related People

Frank
Likely contact at this company
••••••••@••••••••

See Frank's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NorthStar Medical Technologies's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

NorthStar Medical Technologies signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.